HOTH - Hoth Therapeutics shoots up on securing the rights for breath-based COVID-19 testing device August, 10 2020 09:24 AM Hoth Therapeutics Inc. Hoth Therapeutics (NASDAQ:HOTH) jumps 25% premarket on its announcement of licensing IP rights to develop real-time mobile testing device that has the potential to immediately diagnose COVID-19 infection through breath sample.More news on: Hoth Therapeutics, Inc., Healthcare stocks news, Read more ...